About
About KSM
KSM (Kahn-Sagol-Maccabi) is the Research and Innovation center of Maccabi Healthcare Services, the leading HMO in Israel.
Team
Come meet us
Join us
Come join our super talented team
Contact us
info@ksminnovation.com
What We Do
Innovation and Big Data
KSM is leading the way with cutting-edge medical technology.
Epidemiological Research
Maccabi's longitudinal data is useful for analyzing diseases and medication patterns.
Biobank
We conduct a wide range of genetic and biological studies that promote quality personalized healthcare.
Technology and Data Infrastructure
R&D, Infrastructure, Data Science, Data Analysis & Engineering.
Clinical Research
A "one-stop shop" for researchers from planning to execution.
Research and Development
Cutting edge methodologies for retrospective research.
News & Publications
News
Our latest news
Scientific Publications
Medical publications by KSM researchers
Podcast
Subscribe
Contact
About
About KSM
Team
Join us
Contact
What We Do
Innovation and Big Data
Biobank
Clinical Research
Epidemiological Research
Technology and Data Infrastructure
Research and Development
News & Publications
News
Scientific Publications
Podcast
Subscribe to our newsletter
Contact
KSM Feed
In the news
Wednesday, 3rd May 2023
More asthma sufferers live in areas with high levels of pollution
In Hebrew
Wednesday, 3rd May 2023
For World Asthma Day, we examined air quality ratios in various geographic locations in Israel, and the prevalence of Asthma...
In Hebrew
Wednesday, 3rd May 2023
BioBank and Genetic Research: Dr. Tal Patalon, Head of KSM, discusses these topics on Kan Radio.
Thursday, 2nd March 2023
PUBLISHED IN THE JOURNAL OF PEDIATRICS: Continuing our efforts to better understand natural and hybrid immunity in children and Adolescents
Monday, 22nd August 2022
KSM research on natural immunity.
In Hebrew
Monday, 25th July 2022
Globes: Monkeypox – Dr. Tal Patalon explaination her view.
In Hebrew
Monday, 11th July 2022
Monkeypox in a developing country: A Case Report.
Wednesday, 29th June 2022
Delta reinfection risk low among unvaccinated children.
Friday, 24th June 2022
KSM study: Immunity against COVID-19 among children many months after infection.
Thursday, 23rd June 2022
Our new study on the duration of protection conferred by a previous SARS-CoV-2 infection amongst children and adolescents.
Thursday, 9th June 2022
Waning effectiveness of third dose of BNT162b2 vaccine.
Tuesday, 24th May 2022
Effectiveness of the 4th dose of Pfizer’s COVID-19 vaccine wanes after 10 weeks, sooner than previous doses.
In Hebrew
Monday, 28th March 2022
Our new COVID-19 4th shot study continues to make headlines.
In Hebrew
Sunday, 27th March 2022
Our Deputy Head Dr. Sivan Gazit on Channel 13 evening news.
In Hebrew
Saturday, 26th March 2022
The 4th dose of the BNT162b2 vaccine provides at least 73% protection against SARS-CoV-2 severe illness relative to three doses.
Load more
Thank you
Thank you for subscribing our newslatter. you can unsubscribe anytime you wish.
Back to home
Your browser does not support the video tag.